Rufei Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rufei Shen has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Deyu Yuan
Department of Ultrasound, Xinqiao Hospital, Army Medical University, 400037 Chongqing, China
1 shared publication - Haiyan Li
Department of Ultrasound, Xinqiao Hospital, Army Medical University, 400037 Chongqing, China
1 shared publication - Hui Li
Department of Ultrasound, Xinqiao Hospital Army Medical University Chongqing China
1 shared publication - Hui Yang
Department of Neurosurgery, Xinqiao Hospital, Army Medical University, Chongqing, China
1 shared publication - Jing-Peng Liu
Department of Urology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China
1 shared publication - Junhui Tang
Department of Ultrasound, the General Hospital of Tibet Military Command
1 shared publication
Latest Publications
- Open Access
- 28 September 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (9)
Effects of Hormones on Left Heart Structure and Function with Echocardiography in Acromegaly
Background: The relationship between growth hormone (GH) and changes in cardiac morphology and function in the current study has not been fully elucidated, and this study aimed to assess the effect of hormonal factors on left ventricular structure and function in acromegaly patients using echocardiography. Methods: We retrospectively analyzed the relationships between various echocardiographic parameters in 117 pre-treatment patients with acromegaly and four hormonal variables: GH, GH nadir during the oral glucose tolerance test (OGTT-GH), insulin-like growth factor-1 (IGF-1), and IGF-1/upper limit of normal (IGF-1/ULN) adjusted for age and sex. Patients were categorized into normal and abnormal subgroups based on interventricular septal (IVS) thickening, left atrial (LA) enlargement, and left ventricular (LV) abnormal LV peak flow velocities E and A (E/A ratios). Furthermore, the hormonal levels within these subgroups were compared. Results: Correlation analysis revealed that IGF-1/ULN was positively associated with IVS thickening and LA enlargement (p = 0.003 and p = 0.001), and negatively associated with an abnormal LV E/A ratio (p < 0.001). Regression analysis identified IGF-1/ULN as a significant risk factor for left heart alterations. Among the four hormonal variables, IGF-1/ULN demonstrated the largest area under the receiver operating characteristic (ROC) curve (AUC), with values of 0.628 for IVS thickening, 0.701 for LA enlargement, and 0.653 for LV abnormal E/A ratio. Conclusion: IGF-1/ULN is strongly associated with changes in left heart structure and function in acromegaly and serves as a risk factor for these alterations. Thus, monitoring IGF-1/ULN may help predict cardiac changes via echocardiography, suggesting that early clinical management of GH-related levels could prevent early cardiac abnormalities in patients with acromegaly.
- 28 September 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (9)
Open AccessEffects of Hormones on Left Heart Structure and Function with Echocardiography in Acromegaly
Background: The relationship between growth hormone (GH) and changes in cardiac morphology and function in the current study has not been fully elucidated, and this study aimed to assess the effect of hormonal factors on left ventricular structure and function in acromegaly patients using echocardiography. Methods: We retrospectively analyzed the relationships between various echocardiographic parameters in 117 pre-treatment patients with acromegaly and four hormonal variables: GH, GH nadir during the oral glucose tolerance test (OGTT-GH), insulin-like growth factor-1 (IGF-1), and IGF-1/upper limit of normal (IGF-1/ULN) adjusted for age and sex. Patients were categorized into normal and abnormal subgroups based on interventricular septal (IVS) thickening, left atrial (LA) enlargement, and left ventricular (LV) abnormal LV peak flow velocities E and A (E/A ratios). Furthermore, the hormonal levels within these subgroups were compared. Results: Correlation analysis revealed that IGF-1/ULN was positively associated with IVS thickening and LA enlargement (p = 0.003 and p = 0.001), and negatively associated with an abnormal LV E/A ratio (p < 0.001). Regression analysis identified IGF-1/ULN as a significant risk factor for left heart alterations. Among the four hormonal variables, IGF-1/ULN demonstrated the largest area under the receiver operating characteristic (ROC) curve (AUC), with values of 0.628 for IVS thickening, 0.701 for LA enlargement, and 0.653 for LV abnormal E/A ratio. Conclusion: IGF-1/ULN is strongly associated with changes in left heart structure and function in acromegaly and serves as a risk factor for these alterations. Thus, monitoring IGF-1/ULN may help predict cardiac changes via echocardiography, suggesting that early clinical management of GH-related levels could prevent early cardiac abnormalities in patients with acromegaly.
- Open Access
- 1 January 2023
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 66 (1) , 72-81
Differences in Clinical Characteristics and Surgical Outcomes of Patients with Ischemic and Hemorrhagic Pituitary Adenomas
Objective : Ischemia and hemorrhage of pituitary adenomas (PA) caused important clinical syndrome. However, the differences on clinical characteristics and surgical outcomes between these two kinds apoplexy were less reported.Methods : A retrospective analysis was made of patients with pituitary apoplexy between January 2013 and June 2018. Baseline and clinical characteristics before surgery were reviewed. All patients underwent transsphenoidal surgery and were followed up at least 1 year.Results : Total 67 cases (5.8%) among 1147 pituitary tumor patients were enrolled, which consisted of 28 (~2.4%) ischemic PA and 39 (~3.4%) hemorrhagic PA. There were more male patients in the ischemic group compared with hemorrhagic group (78.6% vs 53.8%, p=0.043). However, the mean age, tumor size and functional tumor ratio were significant higher in the hemorrhagic group. Headache was more common in ischemic PA (82.1%) than that of hemorrhagic PA (51.3%, p=0.011). Magnetic resonance imaging findings found that mucosal thickening and enhancement of the sphenoid sinus was observed in 15 ischemic PA patients (n=27, 55.6%), but none in patients with hemorrhagic PA (n=38, p<0.0001). It was worth noting that the rate of pre-surgical hypopituitarism in ischemic PA patients were seemed higher than that in hemorrhagic PA patients, but not significant. The two groups got a total tumor resection rate at 94.1% and 92.9%, independently. No significant difference on the operative time, blood loss in operation and complications in perioperative period was observed in two groups. After operation, cranial nerve symptoms recovered to normal at 81.8% of ischemic PA patients and 82.6% of hemorrhagic PA patients. Importantly, the incidence of postoperative hypopituitarism partially decreased in both groups, among which the rate of hypothyroidism in ischemic PA patients significantly decreased from 46.4% to 18.5% (p=0.044).Conclusion : Patients with ischemic PA presented different clinical characteristics to the hemorrhagic ones. Transsphenoidal surgery should be considered for the patients with neuro-ophthalmic deficits and might benefit for pituitary function recovery of the apoplectic adenoma patients, especially pituitary thyroid axis in ischemic PA patients.
- 1 January 2023
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 66 (1) , 72-81
Open AccessDifferences in Clinical Characteristics and Surgical Outcomes of Patients with Ischemic and Hemorrhagic Pituitary Adenomas
Objective : Ischemia and hemorrhage of pituitary adenomas (PA) caused important clinical syndrome. However, the differences on clinical characteristics and surgical outcomes between these two kinds apoplexy were less reported.Methods : A retrospective analysis was made of patients with pituitary apoplexy between January 2013 and June 2018. Baseline and clinical characteristics before surgery were reviewed. All patients underwent transsphenoidal surgery and were followed up at least 1 year.Results : Total 67 cases (5.8%) among 1147 pituitary tumor patients were enrolled, which consisted of 28 (~2.4%) ischemic PA and 39 (~3.4%) hemorrhagic PA. There were more male patients in the ischemic group compared with hemorrhagic group (78.6% vs 53.8%, p=0.043). However, the mean age, tumor size and functional tumor ratio were significant higher in the hemorrhagic group. Headache was more common in ischemic PA (82.1%) than that of hemorrhagic PA (51.3%, p=0.011). Magnetic resonance imaging findings found that mucosal thickening and enhancement of the sphenoid sinus was observed in 15 ischemic PA patients (n=27, 55.6%), but none in patients with hemorrhagic PA (n=38, p<0.0001). It was worth noting that the rate of pre-surgical hypopituitarism in ischemic PA patients were seemed higher than that in hemorrhagic PA patients, but not significant. The two groups got a total tumor resection rate at 94.1% and 92.9%, independently. No significant difference on the operative time, blood loss in operation and complications in perioperative period was observed in two groups. After operation, cranial nerve symptoms recovered to normal at 81.8% of ischemic PA patients and 82.6% of hemorrhagic PA patients. Importantly, the incidence of postoperative hypopituitarism partially decreased in both groups, among which the rate of hypothyroidism in ischemic PA patients significantly decreased from 46.4% to 18.5% (p=0.044).Conclusion : Patients with ischemic PA presented different clinical characteristics to the hemorrhagic ones. Transsphenoidal surgery should be considered for the patients with neuro-ophthalmic deficits and might benefit for pituitary function recovery of the apoplectic adenoma patients, especially pituitary thyroid axis in ischemic PA patients.